Cogent Biosciences Ownership | Who Owns Cogent Biosciences?

Cogent Biosciences Ownership Summary

Cogent Biosciences is owned by 139.08% institutional investors, 0.03% insiders. Fmr is the largest institutional shareholder, holding 19.58% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.91% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cogent Biosciences	139.08%	0.03%	-39.11%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	22.41M	19.58%	$321.78M
Blackrock funding, inc. /de	10.37M	9.06%	$148.91M
Deerfield management company, l.p. (series c)	9.05M	7.91%	$130.00M
Fairmount funds management	9.00M	7.87%	$129.29M
Blackrock	7.29M	7.34%	$61.44M
Kynam capital management, lp	7.89M	6.89%	$113.25M
Vanguard group	7.76M	6.78%	$111.40M
Commodore capital lp	7.25M	6.33%	$104.11M
Tcg crossover management	6.80M	5.94%	$97.62M
State street	4.78M	4.17%	$68.58M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fairmount funds management	9.00M	11.63%	$129.29M
Kynam capital management, lp	7.89M	8.43%	$113.25M
New leaf venture partners	250.76K	8.37%	$3.60M
Saturn v capital management	2.03M	6.38%	$29.08M
Octagon capital advisors lp	2.87M	6.26%	$41.27M
Superstring capital management lp	361.41K	5.11%	$5.19M
Commodore capital lp	7.25M	5.08%	$104.11M
Tcg crossover management	6.80M	4.80%	$97.62M
Boone capital management	945.04K	4.45%	$13.57M
Exome asset management	443.55K	3.86%	$6.37M

Top Buyers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	9.05M	1.98%	6.41M
Fmr	22.41M	0.02%	5.33M
Commodore capital lp	7.25M	5.08%	4.94M
Rtw investments, lp	3.47M	0.61%	3.47M
Fairmount funds management	9.00M	11.63%	2.78M

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	3.16M	1.29%	-7.20M
Point72 asset management	1.24M	0.03%	-3.67M
Vestal point capital, lp	-	-	-3.08M
Frazier life sciences management	-	-	-1.73M
Ubs group	1.85M	0.00%	-1.66M

New Positions

Holder	Shares	% Assets	Change	Value
Rtw investments, lp	3.47M	0.61%	3.47M	$49.79M
Duquesne family office	1.06M	0.37%	1.06M	$15.22M
Boone capital management	945.04K	4.45%	945.04K	$13.57M
Silverarc capital management	815.08K	1.58%	815.08K	$11.70M
Marshall wace, llp	642.48K	0.01%	642.48K	$9.23M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Clear point advisors	-1.00
Cbiz investment advisory services	-3.00
Ifp advisors	-8.00
Nelson, van denburg & campbell wealth management group	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	195	1.56%	159,200,721	17.46%	139	0.99%	125	17.92%	41	5.13%
Jun 30, 2025	191	5.52%	135,507,980	6.74%	118	0.94%	104	8.33%	40	-16.67%
Mar 31, 2025	184	1.10%	133,476,565	9.67%	117	0.97%	98	-	48	2.13%
Dec 31, 2024	179	9.15%	120,758,047	-0.89%	109	0.90%	96	12.94%	48	4.35%
Sep 30, 2024	161	6.62%	121,811,557	0.36%	110	0.74%	84	6.33%	46	-4.17%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	4.06M	2.91%	592.96K
Vanguard US Total Market Shares ETF	3.09M	2.71%	-
Fidelity Select Health Care	3.38M	2.42%	238.90K
Fidelity Advisor Biotechnology I	2.58M	1.85%	581.61K
Fidelity Small Cap Growth	2.57M	1.84%	-
iShares Russell 2000 ETF	2.57M	1.84%	-
FIAM Small Cap Core Composite	1.87M	1.69%	225.12K
Fidelity Advisor Health Care I	1.90M	1.36%	100.00K
FIAM Small Cap Core CIT Cl B	1.83M	1.31%	-15.60K
Fidelity Select Biotechnology	1.57M	1.12%	403.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 10, 2025	Fairmount Funds Management LLC	-	Buy	$25.00M
Jan 14, 2025	Pinnow Cole	Chief Commercial Officer	Buy	$332.41K
Jun 09, 2023	Fairmount Funds Management LLC	-	Buy	$9.60M
Jun 16, 2022	Fairmount Funds Management LLC		Buy	$9.90M
Apr 26, 2021	Green John L.	Chief Financial Officer	Sell	$157.82K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	1	-
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	-	-

COGT Ownership FAQ

Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 139.08%, followed by 0.03% insiders and -39.11% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 45.24%, which Cogent Biosciences exceeds.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Fmr (22.41M shares, 19.58%), Blackrock funding, inc. /de (10.37M shares, 9.06%), and Deerfield management company, l.p. (series c) (9.05M shares, 7.91%). Together, they hold 36.54% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 11.63% of its assets in 9M Cogent Biosciences shares, valued at 129.29M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cogent Biosciences shares, with 2.91% of its total shares outstanding invested in 4.06M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools